# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000310158-22-000003
Filing Date
2022-02-25
Accepted
2022-02-25 16:44:28
Documents
142
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | mrk-20211231.htm iXBRL | 10-K | 6729616
2 | EXHIBIT-10.17 PLAN FOR DEFERRED PAYMENT OF DIRECTORS COMPENSATION | exhibit1017-planfordeferre.htm | EX-10.17 | 56175
3 | EXHIBIT-10.24 2022 ANNUAL NQSO TERMS AND CONDITIONS | exhibit1024-2022annualnqso.htm | EX-10.24 | 71930
4 | EXHIBIT-10.25 2022 ANNUAL RSU TERMS AND CONDITIONS | exhibit1025-2022annualrsut.htm | EX-10.25 | 75102
5 | EXHIBIT-21 SUBSIDIARY LIST | exhibit21-subsidiarylistas.htm | EX-21 | 363408
6 | EXHIBIT-23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ex23-consentofindependentr.htm | EX-23 | 2590
7 | EXHIBIT-24.1 POWER OF ATTORNEY | ex241-powerofattorney1.htm | EX-24.1 | 14768
8 | EXHIBIT-24.2 CERTIFICATION OF BOARD RESOLUTION | ex242-certificationofboard.htm | EX-24.2 | 7116
9 | EXHIBIT-31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO | ex311-rule13ax14a15dx14ace.htm | EX-31.1 | 8344
10 | EXHIBIT-31.2 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO | ex312-rule13ax14a15dx14ace.htm | EX-31.2 | 8390
11 | EXHIBIT-32.1 SECTION 1350 CERTIFICATION OF CEO | ex321-section1350certifica.htm | EX-32.1 | 4264
12 | EXHIBIT-32.2 SECTION 1350 CERTIFICATION OF CFO | ex322-section1350certifica.htm | EX-32.2 | 3849
18 |  | mrk-20211231_g1.jpg | GRAPHIC | 77915
19 |  | mrk-20211231_g2.gif | GRAPHIC | 5605
20 |  | mrk-20211231_g3.jpg | GRAPHIC | 31485
21 |  | mrk-20211231_g4.jpg | GRAPHIC | 17845
| Complete submission text file | 0000310158-22-000003.txt |  | 30000763

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20211231.xsd | EX-101.SCH | 124315
14 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20211231_cal.xml | EX-101.CAL | 204839
15 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20211231_def.xml | EX-101.DEF | 826492
16 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20211231_lab.xml | EX-101.LAB | 1594963
17 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20211231_pre.xml | EX-101.PRE | 1162996
136 | EXTRACTED XBRL INSTANCE DOCUMENT | mrk-20211231_htm.xml | XML | 7213715

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-06571 | Film No.: 22681109
SIC: 2834 Pharmaceutical Preparations